Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Elasmogen Ltd logo — To improve the outcomes and quality of life for people comba...

Elasmogen Ltd

To improve the outcomes and quality of life for people combating disease now, and in the future.

Founded 2016 14 employees Series Unknown Total: $13.57M Health and Wellness

General Information

Company Name Elasmogen Ltd
Founded Year 2016
Employees 14
Industries Health and Wellness
Funding Stage Series Unknown
Social

Get notified when Elasmogen Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Elasmogen Ltd

Elasmogen is a biotechnology startup founded in 2016, with a mission to improve outcomes and quality of life for individuals battling difficult-to-treat diseases. The company's focus lies in developing multi-functional therapeutic biologics utilizing its proprietary soloMER technology. This includes the creation of first-in-class drug conjugates (SDC) and bi-specific products for treating autoimmune diseases. Moreover, Elasmogen's pipeline also encompasses soloMER-targeted RadioPharmaceutical Therapies (RPT) tailored for solid tumor cancers in the oncology domain. The company recently secured a notable £8.00M Venture Round investment on 18 May 2022. This funding round saw participation from various key investors including Scottish Enterprise, Scottish National Investment Bank, and Business Growth Fund, signifying noteworthy support from both public and private funding entities. Elasmogen's compelling focus on leveraging its proprietary technology to address challenging medical conditions, coupled with the recent substantial investment, positions the company as a promising player in the biotech landscape. With a keen eye on research and development, the company appears poised to make significant strides in the therapeutic biologics space, thereby attracting attention from potential venture capital partners seeking to contribute to impactful and innovative healthcare solutions.

Taxonomy: biologics, soloMERs, auto-inflammatory diseases, therapeutics, ophthalmology, oncology, inflammatory illnesses, biologic technology, clinical candidates, immunotherapy, drug discovery, patent landscape, innovation, biotech startups

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 3
Investor Investor
•••• •••• 		18 May 2022
Grant •••••• 1
Investor
08 Jul 2020
Venture Round •••••• 1
Investor
10 Jan 2020
Grant •••••• 1
Investor
13 Aug 2018
Seed Round •••••• 2
Investor
•••• •••• 		16 Mar 2017

View All 7 Funding Rounds

Elasmogen Ltd Alternatives & Competitors

Elasmogen Ltd vs
Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. United States

Aclaris is committed to developing innovative therapies to address the needs of people with immuno-i...

71 employees
Elasmogen Ltd vs
Atlantic Healthcare
Atlantic Healthcare

Innovating therapeutic solutions for gastrointestinal diseases and unmet patient needs worldwide

Series B
Biotechnology, Health Care
Elasmogen Ltd vs
Nuvig Therapeutics Inc.
Nuvig Therapeutics Inc. United States

Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases

Series A
24 employees
Biotechnology, Health Care

FAQ About Elasmogen Ltd

To improve the outcomes and quality of life for people combating disease now, and in the future.
Elasmogen Ltd was founded in 2016.
Elasmogen Ltd operates in the following industries: Health and Wellness.
Elasmogen Ltd has approximately 14 employees.
Elasmogen Ltd has completed 7 funding rounds, raising a total of $13.57M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Elasmogen Ltd include Aclaris Therapeutics, Inc., Atlantic Healthcare, Nuvig Therapeutics Inc., Cellenkos, Inc., Rhizen Pharmaceuticals AG. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Elasmogen Ltd and Aclaris Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Elasmogen Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes